DuPont
DD
$48.04
-1.03%
DuPont de Nemours, Inc. is a diversified global specialty chemicals company formed from the DowDuPont merger and subsequent separations. It operates as a major player in the specialty chemicals industry, producing materials for critical end markets including healthcare, water treatment, construction, automotive, aerospace, and electronics. The company is currently navigating a post-transformation phase, with investor focus centered on its ability to demonstrate pricing power, execute on strategic portfolio optimization, and deliver consistent profitability amidst a challenging macroeconomic environment for industrial materials, as evidenced by recent news highlighting strong quarterly results and an accelerated share buyback program.…
DD
DuPont
$48.04
Related headlines
Investment Opinion: Should I buy DD Today?
Rating & Thesis: Hold. DuPont presents a high-risk, high-potential-reward situation where compelling financial strength and analyst conviction are counterbalanced by severe operational instability and an extended stock price; investors should await clearer signs of fundamental stabilization before establishing new positions, noting the unanimous bullish analyst ratings but lack of a clear consensus price target.
Supporting Evidence: The stock trades at a forward PE of 18.44x, which is not excessive if profitability returns as expected, but the negative trailing PE and ROE of -5.60% underscore current challenges. The Price-to-Sales ratio of 2.45x is near the low end of its own historical range, suggesting a valuation discount. Strong free cash flow of $1.08 billion and a low debt-to-equity ratio of 0.23 provide a solid financial foundation. However, the catastrophic 45.25% YoY revenue decline in the latest quarter is a major red flag that overshadows these positive metrics.
Risks & Conditions: The two biggest risks are 1) the revenue decline proving structural rather than one-time, and 2) the company failing to return to consistent net profitability. This Hold rating would upgrade to a Buy if quarterly revenue stabilizes above $3 billion and the company returns to positive net income for two consecutive quarters, confirming the turnaround. It would downgrade to a Sell if revenue continues to decline sequentially or if free cash flow turns negative. Based on the current mix of strong finances and weak operations, the stock appears fairly valued, pricing in a recovery that is not yet evident in the reported numbers.
Sign up to view all
DD 12-Month Price Forecast
The outlook for DuPont is a coin flip between stabilization and continued struggle. The company's financial fortress and analyst support provide a floor, but the catastrophic revenue drop and lack of current profitability create a ceiling. The base case (50% probability) of range-bound trading is most likely, as the market digests whether the strong Q1 2026 news is a true inflection point. The stance would upgrade to bullish on confirmation of revenue stabilization and a return to net profitability for two consecutive quarters. It would turn bearish if the next earnings report shows further deterioration in top-line performance or cash flow.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on DuPont's 12-month outlook, with a consensus price target around $62.45 and implied upside of +30.0% versus the current price.
Average Target
$62.45
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$38 - $62
Analyst target range
Insufficient analyst coverage data is available to provide a detailed consensus view, as the provided analyst data only includes five analysts' estimates for EPS and revenue, without explicit price targets or Buy/Hold/Sell ratings. The limited number of analysts (5) covering the stock suggests it may have lower institutional visibility, which is somewhat surprising for a company of DuPont's size and legacy. This can lead to higher volatility and less efficient price discovery compared to more heavily covered peers. The available institutional ratings show a consistently bullish sentiment among the firms that have recently published research, with all ten entries from firms like Deutsche Bank, Citigroup, UBS, and JP Morgan being Buy, Outperform, or Overweight ratings, and no downgrades. This unanimous bullish stance from covering analysts, combined with the company's own positive operational news, indicates strong professional conviction in the near-to-medium term story, even in the absence of a quantifiable consensus target price and implied upside.
Bulls vs Bears: DD Investment Factors
The bull case for DuPont is anchored by its fortress-like balance sheet, strong cash generation, and unanimous bullish sentiment from the analysts who cover it. The bear case is equally compelling, driven by severe revenue volatility, recent net losses, and a stock price that appears extended after a massive rally. Currently, the bearish evidence holds more weight due to the concrete, negative fundamentals of a 45% revenue decline and negative ROE, which are more immediate and severe than the bullish financial flexibility. The single most important tension in the investment debate is whether the company's strong cash flow and balance sheet can successfully fund a turnaround that stabilizes revenues and returns the business to consistent profitability, thereby justifying the forward-looking valuation multiple the market has already assigned.
Bullish
- Strong Balance Sheet & Cash Flow: DuPont maintains a robust financial position with a low debt-to-equity ratio of 0.23 and a strong current ratio of 2.42. This is supported by substantial trailing twelve-month free cash flow of $1.08 billion, providing significant flexibility for strategic initiatives like the recently announced accelerated share buyback program.
- Unanimous Analyst Conviction: Despite limited coverage, the ten most recent institutional ratings from major banks (Deutsche Bank, Citigroup, UBS, JP Morgan) are unanimously bullish (Buy/Outperform/Overweight). This strong professional conviction, coupled with recent positive news on pricing power, signals confidence in the near-to-medium term outlook.
- Attractive Valuation vs. Own History: The stock trades at a Price-to-Sales (PS) ratio of 2.45x, which is near the lower end of its recent historical range (as high as 9.82x in Q4 2025). This suggests the market may be undervaluing the company relative to its own past multiples, presenting a potential value opportunity if fundamentals stabilize.
- Significant Technical Momentum: The stock has gained 68.53% over the past year, significantly outperforming the S&P 500's 22.86% gain. This strong long-term uptrend, from a 52-week low of $27.45 to a recent high of $52.66, indicates substantial investor confidence and positive price discovery.
Bearish
- Severe Revenue Volatility & Decline: The most recent quarterly revenue of $1.69 billion represents a dramatic 45.25% year-over-year decline. While this may involve one-time items or divestitures, such extreme volatility complicates the growth narrative and raises concerns about underlying business stability and core demand.
- Persistent Profitability Challenges: The company reported a net loss of $126 million in Q4 2025, with a negative Return on Equity (ROE) of -5.60%. This indicates the company is not currently generating positive returns on shareholder equity, a critical red flag that must be reversed to justify the current market capitalization.
- Extended Price & Recent Underperformance: Trading at $48.26, the stock is only 9% below its 52-week high of $52.66, suggesting limited near-term upside before a major resistance level. Furthermore, it has underperformed the market recently, declining 5.67% over the past month while the S&P 500 was flat, signaling potential exhaustion after the strong rally.
- High Short Interest & Low Coverage: A short ratio of 2.86 indicates significant bearish sentiment from short sellers. Coupled with low analyst coverage (only 5 analysts providing estimates), this suggests the stock may suffer from lower institutional visibility and higher volatility due to less efficient price discovery.
DD Technical Analysis
The stock is in a strong long-term uptrend, evidenced by a 68.53% gain over the past year. Currently trading at $48.26, it sits approximately 82% of the way up from its 52-week low of $27.45 towards its high of $52.66, indicating significant momentum but also proximity to a key resistance level. This positioning near the upper end of the range suggests the stock is extended in the near term, with potential for consolidation or a pullback before attempting a breakout. Recent momentum has diverged from the longer-term trend, with the stock declining 5.67% over the past month, which contrasts sharply with its 7.48% gain over the past three months. This one-month weakness, occurring while the broader market (SPY) was essentially flat (-0.08%), signals a period of underperformance and profit-taking after the strong run-up earlier in the year, potentially setting up a healthier base for future moves. Key technical levels are clearly defined by the 52-week high of $52.66 as major resistance and the 52-week low of $27.45 as major support. A decisive breakout above $52.66 would confirm the resumption of the primary bull trend, while a sustained break below the recent lows around $42.44 could signal a deeper correction. The stock's beta of 1.076 indicates it is slightly more volatile than the overall market, which is typical for a cyclical industrial name and must be factored into risk management decisions.
Beta
1.08
1.08x market volatility
Max Drawdown
-17.6%
Largest decline past year
52-Week Range
$27-$53
Price range past year
Annual Return
+68.9%
Cumulative gain past year
| Period | DD Return | S&P 500 |
|---|---|---|
| 1m | -2.6% | +1.5% |
| 3m | +9.2% | +13.4% |
| 6m | +18.6% | +10.9% |
| 1y | +68.9% | +24.5% |
| ytd | +17.5% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DD Fundamental Analysis
DuPont's revenue trajectory is currently challenged, with the most recent quarterly revenue of $1.693 billion representing a significant 45.25% year-over-year decline. This sharp drop, however, appears to be part of a volatile pattern rather than a consistent downtrend, as the prior quarter (Q3 2025) saw revenue of $3.072 billion. The revenue segment data shows the Electronics & Industrial segment contributed $1.506 billion and Water & Protection contributed $1.359 billion in the latest period, indicating these are the core operational drivers. The extreme quarterly volatility complicates the growth narrative, pointing to potential one-time impacts or segment divestitures. The company's profitability is under pressure, with the latest quarter showing a net loss of $126 million and a gross margin of 31.13%. While the gross margin remains within a reasonable band for a specialty chemicals company, the net loss highlights significant challenges at the operating and net income levels. The operating margin for the quarter was 13.41%, but this was overwhelmed by $293 million in 'total other income expenses net,' leading to the pre-tax and net losses. The path to consistent profitability remains a key focus. The balance sheet and cash flow position show a mixed picture. The company maintains a strong current ratio of 2.42 and a very low debt-to-equity ratio of 0.23, indicating a conservative capital structure with ample liquidity. Trailing twelve-month free cash flow is a robust $1.079 billion, providing significant financial flexibility for dividends, buybacks, and investments. However, the negative Return on Equity (ROE) of -5.60% signals that the company is not currently generating positive returns for shareholders on its equity base, a critical metric that needs to improve to justify the valuation.
Quarterly Revenue
$1.7B
2025-12
Revenue YoY Growth
-0.45%
YoY Comparison
Gross Margin
+0.31%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DD Overvalued?
Given the negative net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 2.45x, which provides a baseline based on current revenue. A forward PE ratio of 18.44x is also available, indicating the market expects a return to profitability, but the PS ratio is more relevant for the current unprofitable state. The gap between the negative trailing PE and the positive forward PE underscores the market's anticipation of a significant earnings recovery in the coming year. Compared to industry averages, DuPont's valuation requires context from its own historical data as no explicit sector multiples were provided in the valuation data. Historically, the stock's PS ratio has fluctuated significantly, reaching as high as 9.82x in Q4 2025 and as low as 3.18x in Q3 2022, based on the historical ratios provided. The current PS of 2.45x sits near the lower end of this observed historical spectrum. This positioning suggests the stock may be trading at a discount to its own history, which could be interpreted as a value opportunity if fundamentals stabilize, or it could reflect a market pricing in a more pessimistic outlook for revenue quality and growth prospects compared to the past.
PE
-21.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -157x~51x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: DuPont's primary financial risk is its volatile and recently collapsing revenue, which fell 45.25% YoY in the latest quarter, coupled with a net loss of $126 million. This earnings volatility, evidenced by a negative trailing PE and ROE of -5.60%, creates significant uncertainty around future profitability. While free cash flow remains strong at $1.08 billion TTM, the company's ability to translate this into sustainable shareholder returns is contingent on reversing the negative income trend. The low debt-to-equity of 0.23 mitigates balance sheet risk but does not address the core operational challenge of stabilizing the top line.
Market & Competitive Risks: The stock's valuation presents a key market risk. While the PS ratio of 2.45x appears low historically, the forward PE of 18.44x embeds high expectations for an earnings recovery. Any failure to meet these expectations could lead to significant multiple compression. As a cyclical industrial stock with a beta of 1.076, DuPont is highly sensitive to broader economic slowdowns, which could pressure demand in its key end markets like automotive and construction. Recent news highlights pricing power, but maintaining this in a potential recession is a competitive challenge.
Worst-Case Scenario: The worst-case scenario involves a failure to stabilize revenues, leading to sustained net losses that erode the strong cash position. This could trigger a loss of analyst confidence (currently unanimously bullish), a dividend cut despite the current 3.56% yield, and a halt to the share buyback program. In this adverse scenario, the stock could re-test its 52-week low of $27.45, representing a potential downside of approximately -43% from the current price of $48.26. A more realistic bear-case target might be a 30-35% decline, aligning with a re-rating to a lower PS multiple amid persistent operational headwinds.
FAQ
The key risks are, in order of severity: 1) Operational Risk: The catastrophic 45.25% YoY revenue decline and negative ROE of -5.60% indicate core business instability. 2) Valuation Risk: The stock is trading near its 52-week high, leaving limited near-term upside and high sensitivity to earnings misses that could compress the forward PE multiple. 3) Macro/Cyclical Risk: With a beta of 1.076, DD is sensitive to economic downturns which could hurt demand in its key industrial end-markets. 4) Sentiment Risk: Low analyst coverage and a high short ratio (2.86) can lead to exaggerated price swings on news, both positive and negative.
The 12-month forecast for DD is bifurcated, with a base case target range of $45 to $52.66 (50% probability), a bull case target of $52.66 to $58 (30% probability), and a bear case target of $27.45 to $40 (20% probability). The base case, which is most likely, assumes the company shows gradual improvement, meets the forward EPS estimate of $3.15, and the stock remains range-bound. The key assumption behind this forecast is that the company's strong cash flow and balance sheet provide enough time and resources to stabilize operations without a further dramatic deterioration in fundamentals.
DD's valuation sends mixed signals. Based on trailing sales, it trades at a Price-to-Sales (PS) ratio of 2.45x, which is near the low end of its own historical range (as high as 9.82x), suggesting it may be undervalued relative to its past. However, the company is currently unprofitable, with a negative trailing PE. The forward PE of 18.44x indicates the market is paying a premium for expected future earnings recovery. Therefore, the stock is neither clearly overvalued nor undervalued; it is fairly valued for a successful turnaround but would be overvalued if the expected profit recovery fails to materialize.
DD is a high-risk, high-potential-reward stock that is not a straightforward 'good buy' for all investors. For risk-tolerant investors who believe in the management's ability to execute a turnaround, the strong balance sheet (D/E 0.23) and unanimous bullish analyst ratings are compelling. However, the severe 45% YoY revenue decline and recent net losses present substantial fundamental risk. The stock appears fairly valued at a forward PE of 18.44x, pricing in a recovery that has not yet materialized. It could be a good buy for speculative portfolios after evidence of operational stabilization, but conservative investors should avoid it until profitability is consistently restored.
DD is not suitable for short-term trading due to its fundamental volatility, extended price near 52-week highs, and sensitivity to quarterly earnings surprises. Its beta of 1.076 also implies higher volatility than the market. The investment thesis is fundamentally a medium-to-long-term turnaround story, requiring at least 2-3 years to see if management can leverage the strong balance sheet to return the company to consistent growth and profitability. The 3.56% dividend yield adds an income component for long-term holders, but the primary driver will be capital appreciation from a successful operational recovery. A minimum holding period of 18-24 months is suggested to evaluate the success of the transformation.
